Literature DB >> 7726641

Proopiomelanocortin production by epidermal cells: evidence for an immune neuroendocrine network in the epidermis.

R S Bhardwaj1, T A Luger.   

Abstract

Proopiomelanocortin (POMC) is known to be synthesized in the pituitary gland and is subsequently cleaved by specific prohormone convertases into biologically active peptide hormones such as melanocyte stimulating hormones (MSH), adrenocorticotropin (ACTH) and endorphins (EP). Guanine nucleotide-binding protein (G-protein)-coupled receptors, which have only recently been discovered, are involved in the transmission of their message. There is also evidence indicating that POMC is not only produced by pituitary cells but is an ubiquitous molecule, that is cleaved cell- and tissue-specific. It has also been shown that the epidermis keratinocytes as well as melanocytes express POMC upon stimulation and release alpha MSH and ACTH. In addition to their function as hormones, POMC peptides have been shown to exert a variety of immunoregulatory effects by modulating the function of immunocompetent cells as well as cytokines. These findings provide further evidence for the immunoneuroendocrine network playing a crucial role during the pathogenesis of immune and inflammatory skin disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7726641     DOI: 10.1007/bf00370724

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  53 in total

Review 1.  T-cell tolerance in transgenic mice expressing major histocompatibility class I molecules in defined tissues.

Authors:  J F Miller; G Morahan; J Allison; P S Bhathal; K O Cox
Journal:  Immunol Rev       Date:  1989-02       Impact factor: 12.988

2.  MSH peptides are present in mammalian skin.

Authors:  A J Thody; K Ridley; R J Penny; R Chalmers; C Fisher; S Shuster
Journal:  Peptides       Date:  1983 Nov-Dec       Impact factor: 3.750

3.  Studies on corticotropin-induced desensitization of normal rat adrenocortical cells.

Authors:  C S Rani; G Keri; J Ramachandran
Journal:  Endocrinology       Date:  1983-01       Impact factor: 4.736

4.  Regulation of corticotropin receptor number and messenger RNA in cultured human adrenocortical cells by corticotropin and angiotensin II.

Authors:  M C Lebrethon; D Naville; M Begeot; J M Saez
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

5.  The cloning of a family of genes that encode the melanocortin receptors.

Authors:  K G Mountjoy; L S Robbins; M T Mortrud; R D Cone
Journal:  Science       Date:  1992-08-28       Impact factor: 47.728

6.  The neural and neuro-endocrine component of the human thymus. II. Hormone immunoreactivity.

Authors:  E Batanero; F E de Leeuw; G H Jansen; D F van Wichen; J Huber; H J Schuurman
Journal:  Brain Behav Immun       Date:  1992-09       Impact factor: 7.217

7.  Ontogeny of the prohormone convertases PC1 and PC2 in the mouse hypophysis and their colocalization with corticotropin and alpha-melanotropin.

Authors:  M Marcinkiewicz; R Day; N G Seidah; M Chrétien
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

8.  Alpha melanocyte stimulating hormone inhibits immunostimulatory and inflammatory actions of interleukin 1.

Authors:  J G Cannon; J B Tatro; S Reichlin; C A Dinarello
Journal:  J Immunol       Date:  1986-10-01       Impact factor: 5.422

9.  Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA.

Authors:  V Chhajlani; J E Wikberg
Journal:  FEBS Lett       Date:  1992-09-14       Impact factor: 4.124

10.  Neuropeptide regulation of inflammatory and immunologic responses. The capacity of alpha-melanocyte-stimulating hormone to inhibit tumor necrosis factor and IL-1-inducible biologic responses.

Authors:  B Robertson; K Dostal; R A Daynes
Journal:  J Immunol       Date:  1988-06-15       Impact factor: 5.422

View more
  8 in total

1.  Staphylococcal exfoliative toxins cleave alpha- and beta-melanocyte-stimulating hormones.

Authors:  J V Rago; G M Vath; T J Tripp; G A Bohach; D H Ohlendorf; P M Schlievert
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

Review 2.  Atopic dermatitis and the nervous system.

Authors:  Laurent Misery
Journal:  Clin Rev Allergy Immunol       Date:  2011-12       Impact factor: 8.667

Review 3.  POMC: The Physiological Power of Hormone Processing.

Authors:  Erika Harno; Thanuja Gali Ramamoorthy; Anthony P Coll; Anne White
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

4.  Proopiomelanocortin (POMC), the ACTH/melanocortin precursor, is secreted by human epidermal keratinocytes and melanocytes and stimulates melanogenesis.

Authors:  Karine Rousseau; Sobia Kauser; Lynn E Pritchard; Anne Warhurst; Robert L Oliver; Andrzej Slominski; Edward T Wei; Anthony J Thody; Desmond J Tobin; Anne White
Journal:  FASEB J       Date:  2007-02-22       Impact factor: 5.191

5.  Crucial role of the melanocortin receptor MC1R in experimental colitis.

Authors:  C Maaser; K Kannengiesser; C Specht; A Lügering; T Brzoska; T A Luger; W Domschke; T Kucharzik
Journal:  Gut       Date:  2006-03-16       Impact factor: 23.059

Review 6.  Melanocortin peptides: potential targets in systemic lupus erythematosus.

Authors:  Lisa Carole Loram; Melissa Elizabeth Culp; Erin Corey Connolly-Strong; Sheila Sturgill-Koszycki
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

7.  Melanin production through novel processing of proopiomelanocortin in the extracellular compartment of the auricular skin of C57BL/6 mice after UV-irradiation.

Authors:  Hiroyuki Yamamoto; Tomohiro Yamane; Kazuaki Iguchi; Kiyotaka Tanaka; Arunasiri Iddamalgoda; Keiko Unno; Minoru Hoshino; Atsushi Takeda
Journal:  Sci Rep       Date:  2015-09-29       Impact factor: 4.379

8.  Contralateral needling at unblocked collaterals for hemiplegia following acute ischemic stroke.

Authors:  Huanmin Gao; Xugang Li; Xia Gao; Benxu Ma
Journal:  Neural Regen Res       Date:  2013-11-05       Impact factor: 5.135

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.